IN2015DN02894A - - Google Patents

Info

Publication number
IN2015DN02894A
IN2015DN02894A IN2894DEN2015A IN2015DN02894A IN 2015DN02894 A IN2015DN02894 A IN 2015DN02894A IN 2894DEN2015 A IN2894DEN2015 A IN 2894DEN2015A IN 2015DN02894 A IN2015DN02894 A IN 2015DN02894A
Authority
IN
India
Prior art keywords
disease
field
relates
airway
pulmonary disease
Prior art date
Application number
Other languages
English (en)
Inventor
Balazs; Albrecht
Michael; Aven
Janine; Lamar
Ingo; Lang
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47552829&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2015DN02894(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of IN2015DN02894A publication Critical patent/IN2015DN02894A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
IN2894DEN2015 2012-12-21 2013-12-18 IN2015DN02894A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12199302 2012-12-21
PCT/EP2013/077265 WO2014096115A1 (en) 2012-12-21 2013-12-18 Ciclesonide for the treatment of airway disease in horses

Publications (1)

Publication Number Publication Date
IN2015DN02894A true IN2015DN02894A (pt) 2015-09-11

Family

ID=47552829

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2894DEN2015 IN2015DN02894A (pt) 2012-12-21 2013-12-18

Country Status (24)

Country Link
US (4) US9918995B2 (pt)
EP (1) EP2934479B1 (pt)
AR (1) AR094241A1 (pt)
AU (2) AU2013360691B2 (pt)
BR (2) BR122016029247A2 (pt)
CA (1) CA2888428C (pt)
CY (2) CY1121115T1 (pt)
DK (1) DK2934479T3 (pt)
ES (1) ES2693779T3 (pt)
FR (1) FR20C1026I1 (pt)
HR (1) HRP20181980T1 (pt)
HU (1) HUS2000020I1 (pt)
IN (1) IN2015DN02894A (pt)
LT (2) LT2934479T (pt)
MA (1) MA38169B2 (pt)
MX (1) MX368306B (pt)
NO (1) NO2020014I1 (pt)
NZ (1) NZ706573A (pt)
PL (1) PL2934479T3 (pt)
PT (1) PT2934479T (pt)
RS (1) RS57740B1 (pt)
SI (1) SI2934479T1 (pt)
WO (1) WO2014096115A1 (pt)
ZA (1) ZA201502288B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014003117A2 (pt) 2011-08-12 2017-06-13 Boehringer Ingelheim Vetmedica Gmbh inibidores da corrente funny (if) para uso em um método de tratamento e prevenção de insuficiência cardíaca em felino
RS57740B1 (sr) 2012-12-21 2018-12-31 Boehringer Ingelheim Vetmedica Gmbh Ciklezonid za lečenje oboljenja disajnih puteva kod konja
DK2934544T3 (en) 2012-12-21 2019-03-04 Boehringer Ingelheim Vetmedica Gmbh PHARMACEUTICAL FORMULA INCLUDING CICLESONID
SI3157522T1 (sl) 2014-06-18 2020-01-31 Boehringer Ingelheim Vetmedica Gmbh Muskarinski antagonisti in njihove kombinacije za zdravljenje bolezni dihalne poti pri konjih
WO2018070819A1 (ko) * 2016-10-14 2018-04-19 제주대학교 산학협력단 시클레소나이드를 포함하는, 암 줄기세포 성장 억제용 조성물
US20230033224A1 (en) * 2020-01-10 2023-02-02 Boehringer Ingelheim Vetmedica Gmbh Ciclesonide for ameliorating quality of life (qol) in equines
MX2023001201A (es) 2020-07-31 2023-05-03 Chemo Res S L Terapia combinada para la administracion por inhalacion.

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954049A (en) 1991-10-15 1999-09-21 Trudell Medical Limited Equine mask with MDI adapter
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
US5823179A (en) 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US6264923B1 (en) * 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
DE10050994A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10062712A1 (de) 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US6904908B2 (en) 2002-05-21 2005-06-14 Trudell Medical International Visual indicator for an aerosol medication delivery apparatus and system
DE10237739A1 (de) 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
US7244742B2 (en) 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
AU2003272450A1 (en) 2002-09-13 2004-04-30 C. Steven Smith Novel composition and method for treatment of upper respiratory conditions
WO2004103379A1 (en) * 2003-05-22 2004-12-02 Altana Pharma Ag Salmeterol and ciclesonide combination
US20050020692A1 (en) 2003-07-24 2005-01-27 Ciofalo Vincent B. Treatment of heaves
PT1670482E (pt) 2003-09-16 2014-03-12 Takeda Gmbh Utilização de ciclesonida para o tratamento de doenças respiratórias
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
WO2005102354A1 (en) 2004-04-20 2005-11-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
EP1763344A1 (en) 2004-06-29 2007-03-21 Boehringer Ingelheim International GmbH Medicaments for inhalation comprising steroids and an anticholinergic
DE102004056579A1 (de) 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid
UY30542A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
UY30543A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
NZ596456A (en) 2009-06-25 2014-01-31 Boehringer Ingelheim Vetmed Inhaler
US7829748B1 (en) 2009-09-21 2010-11-09 Honeywell International Inc. Process for the manufacture of 1,3,3,3-tetrafluoropropene
EA201590030A1 (ru) 2012-07-05 2015-09-30 Арвен Айлак Санайи Ве Тиджарет А.С. Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы, и третий компонент
US20150202148A1 (en) 2012-07-05 2015-07-23 Arven llac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhalers comprising a carrier other than lactose
US9539408B2 (en) 2012-10-31 2017-01-10 Trudell Medical International Nebulizer apparatus
DK2934544T3 (en) 2012-12-21 2019-03-04 Boehringer Ingelheim Vetmedica Gmbh PHARMACEUTICAL FORMULA INCLUDING CICLESONID
RS57740B1 (sr) 2012-12-21 2018-12-31 Boehringer Ingelheim Vetmedica Gmbh Ciklezonid za lečenje oboljenja disajnih puteva kod konja
LT3632373T (lt) 2013-08-20 2023-10-10 Boehringer Ingelheim Vetmedica Gmbh Inhaliatorius
DK3035886T3 (da) 2013-08-20 2021-01-04 Boehringer Ingelheim Vetmedica Gmbh Inhalator
SI3157522T1 (sl) 2014-06-18 2020-01-31 Boehringer Ingelheim Vetmedica Gmbh Muskarinski antagonisti in njihove kombinacije za zdravljenje bolezni dihalne poti pri konjih

Also Published As

Publication number Publication date
US20150313918A1 (en) 2015-11-05
NZ706573A (en) 2019-11-29
US20170079988A1 (en) 2017-03-23
MA38169A1 (fr) 2017-01-31
AU2013360691B2 (en) 2018-03-08
AU2018201642B2 (en) 2019-01-31
BR112015010842A2 (pt) 2017-07-11
WO2014096115A1 (en) 2014-06-26
PT2934479T (pt) 2018-12-20
SI2934479T1 (sl) 2019-01-31
RS57740B1 (sr) 2018-12-31
EP2934479A1 (en) 2015-10-28
MX2015007947A (es) 2015-10-08
CA2888428A1 (en) 2014-06-26
CY1121115T1 (el) 2019-12-11
BR112015010842B1 (pt) 2021-03-30
CA2888428C (en) 2021-07-13
EP2934479B1 (en) 2018-09-19
MX368306B (es) 2019-09-27
HRP20181980T1 (hr) 2019-01-25
CY2020015I1 (el) 2020-11-25
US20140179651A1 (en) 2014-06-26
AU2013360691A1 (en) 2015-04-16
US10441597B2 (en) 2019-10-15
MA38169B2 (fr) 2021-08-31
CY2020015I2 (el) 2021-03-12
BR112015010842A8 (pt) 2019-10-01
LT2934479T (lt) 2018-12-27
FR20C1026I1 (fr) 2020-10-02
US9918995B2 (en) 2018-03-20
PL2934479T3 (pl) 2019-02-28
BR122016029247A2 (pt) 2019-08-20
ZA201502288B (en) 2019-09-25
NO2020014I1 (no) 2020-06-12
AR094241A1 (es) 2015-07-22
ES2693779T3 (es) 2018-12-13
US20180153907A1 (en) 2018-06-07
HUS2000020I1 (hu) 2020-07-28
US10258634B2 (en) 2019-04-16
AU2018201642A1 (en) 2018-03-29
LTPA2020511I1 (lt) 2020-07-27
DK2934479T3 (en) 2018-11-05

Similar Documents

Publication Publication Date Title
IN2015DN02894A (pt)
UA109868C2 (ru) Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar)
MX2021007268A (es) Formas solidas de acido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acetico, composiciones, y usos de las mismas.
WO2014179564A8 (en) Thiazolopyrrolidine inhibitors of ror-gamma
MX2019014935A (es) Antagonistas muscarinicos y sus combinaciones para el tratamiento de enfermedades de las vias respiratorias en caballos.
PH12016500024A1 (en) Bromodomain inhibitor
IN2014DN09352A (pt)
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
EA201490228A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
MX344238B (es) Compuestos de tetrazol y métodos para preparar y usar los mismos.
WO2014151456A3 (en) Treatment of inflammatory diseases
EA032951B1 (ru) Производное глутаримидов, его применение, фармацевтическая композиция на его основе, способ его получения
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
IN2014DN09347A (pt)
ZA201203281B (en) Pharmaceutical combinations, pharmaceutical compositions, medicament and method for the treatment of animals
WO2016011049A3 (en) Compositions and methods for disease treatment using nanoparticle delivered compounds
HK1197235A1 (zh) 二氫吡唑、其藥物組合物及其治療生育障礙的用途
WO2012021800A3 (en) Caspase inhibitors as therapeutics for neural and organ injury and imaging
MX2015001657A (es) Compuestos de cianopirazol substituidos con receptores de acido lisofosfatidico (lpar).
WO2014138616A3 (en) Pyrazole compounds and methods of use thereof
EP2431049A4 (en) Pharmaceutical preparation for administration to the respiratory system Prevention of inflammatory respiratory diseases and methods of treatment or PREVENTION OF SUCH DISEASES
WO2015003049A3 (en) Compositions and methods to treat inflammatory joint disease
WO2015004634A3 (es) Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio
EP3085691A4 (en) Method for preparing the anhydrous crystalline form of isoniazid-derived hydrazone, thus produced crystalline polymorph of the anhydrous form, use thereof for the treatment of alzheimer's disease, parkinsonism and other neurodegenerative disorders, and pharmaceutical composition
IN2013MU03429A (pt)